nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupranolol—Clenbuterol—TNF—hematologic cancer	0.00795	0.514	CrCbGaD
Bupranolol—Timolol—ABCB1—hematologic cancer	0.00419	0.271	CrCbGaD
Bupranolol—Nadolol—ABCB1—hematologic cancer	0.00333	0.215	CrCbGaD
Bupranolol—ADRB1—Signaling Pathways—CXCR4—hematologic cancer	0.000299	0.000303	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—FBXW7—hematologic cancer	0.000298	0.000303	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—FN1—hematologic cancer	0.000296	0.000301	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—NFKBIA—hematologic cancer	0.000292	0.000297	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—BAD—hematologic cancer	0.000292	0.000297	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HDAC2—hematologic cancer	0.000292	0.000297	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CXCR4—hematologic cancer	0.000292	0.000297	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CBL—hematologic cancer	0.000291	0.000296	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—NOTCH1—hematologic cancer	0.00029	0.000294	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IL3—hematologic cancer	0.000288	0.000293	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CBL—hematologic cancer	0.000285	0.000289	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—PIK3CG—hematologic cancer	0.000285	0.000289	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CD80—hematologic cancer	0.000284	0.000288	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PIK3CG—hematologic cancer	0.000283	0.000288	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—KIT—hematologic cancer	0.000283	0.000288	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—NRAS—hematologic cancer	0.000283	0.000288	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PTPN1—hematologic cancer	0.000283	0.000288	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IL3—hematologic cancer	0.000282	0.000286	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—PTPN11—hematologic cancer	0.00028	0.000284	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—RASGRP1—hematologic cancer	0.000279	0.000283	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—PIK3CG—hematologic cancer	0.000278	0.000283	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PTPN11—hematologic cancer	0.000278	0.000283	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HSP90AA1—hematologic cancer	0.000278	0.000282	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—SYK—hematologic cancer	0.000278	0.000282	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PTPN1—hematologic cancer	0.000277	0.000281	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—PIK3CD—hematologic cancer	0.000275	0.00028	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—PTPN11—hematologic cancer	0.000273	0.000278	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—RASGRP1—hematologic cancer	0.000272	0.000277	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HSP90AA1—hematologic cancer	0.000272	0.000276	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—SYK—hematologic cancer	0.000272	0.000276	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—MAPK3—hematologic cancer	0.000271	0.000275	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CREB1—hematologic cancer	0.000271	0.000275	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CREB1—hematologic cancer	0.00027	0.000274	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—PIK3CD—hematologic cancer	0.000269	0.000274	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—STAT1—hematologic cancer	0.000268	0.000272	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—BRAF—hematologic cancer	0.000266	0.00027	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CCL2—hematologic cancer	0.000265	0.000269	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CREB1—hematologic cancer	0.000265	0.000269	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—IL6R—hematologic cancer	0.000264	0.000268	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CCL2—hematologic cancer	0.000264	0.000268	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IL6R—hematologic cancer	0.000263	0.000267	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CREBBP—hematologic cancer	0.000263	0.000267	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—STAT1—hematologic cancer	0.000262	0.000266	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—PIK3R1—hematologic cancer	0.00026	0.000264	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CCL2—hematologic cancer	0.000259	0.000263	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—IL6R—hematologic cancer	0.000258	0.000262	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—PIK3R1—hematologic cancer	0.000254	0.000258	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—JAK2—hematologic cancer	0.000253	0.000257	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—MAP2K1—hematologic cancer	0.000252	0.000256	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MAP2K1—hematologic cancer	0.000251	0.000255	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—GRB2—hematologic cancer	0.00025	0.000254	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—PIK3CD—hematologic cancer	0.00025	0.000254	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PDGFA—hematologic cancer	0.00025	0.000254	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PIK3CD—hematologic cancer	0.000249	0.000253	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—JAK2—hematologic cancer	0.000247	0.000251	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—PIK3CA—hematologic cancer	0.000247	0.00025	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—KITLG—hematologic cancer	0.000246	0.00025	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—MAP2K1—hematologic cancer	0.000246	0.00025	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—GRB2—hematologic cancer	0.000245	0.000249	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—PIK3CD—hematologic cancer	0.000245	0.000249	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PDGFA—hematologic cancer	0.000244	0.000248	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—KRAS—hematologic cancer	0.000244	0.000248	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—KITLG—hematologic cancer	0.000241	0.000245	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—STAT5A—hematologic cancer	0.000241	0.000245	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—PIK3CB—hematologic cancer	0.00024	0.000244	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CDKN2B—hematologic cancer	0.000239	0.000242	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—FGF2—hematologic cancer	0.000238	0.000242	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—PIK3R1—hematologic cancer	0.000236	0.00024	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—STAT5A—hematologic cancer	0.000236	0.000239	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PIK3R1—hematologic cancer	0.000235	0.000239	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—PIK3CB—hematologic cancer	0.000235	0.000239	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CDKN2B—hematologic cancer	0.000233	0.000237	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—PIK3R1—hematologic cancer	0.000231	0.000235	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CD86—hematologic cancer	0.000231	0.000234	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—JAK2—hematologic cancer	0.00023	0.000233	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—JAK2—hematologic cancer	0.000228	0.000232	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HES1—hematologic cancer	0.000228	0.000231	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NCOR1—hematologic cancer	0.000226	0.00023	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CD86—hematologic cancer	0.000226	0.000229	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—JAK2—hematologic cancer	0.000225	0.000228	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—PIK3CA—hematologic cancer	0.000224	0.000227	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CSF2—hematologic cancer	0.000224	0.000227	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—FGF1—hematologic cancer	0.000224	0.000227	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MDM2—hematologic cancer	0.000223	0.000227	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HES1—hematologic cancer	0.000223	0.000226	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NCOR1—hematologic cancer	0.000221	0.000225	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—FOXO1—hematologic cancer	0.000221	0.000224	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—IL2—hematologic cancer	0.00022	0.000224	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PDGFRB—hematologic cancer	0.00022	0.000224	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CSF2—hematologic cancer	0.000219	0.000222	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—FGF1—hematologic cancer	0.000219	0.000222	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—PIK3CB—hematologic cancer	0.000218	0.000221	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PIK3CB—hematologic cancer	0.000217	0.00022	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MTOR—hematologic cancer	0.000217	0.00022	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PDGFRA—hematologic cancer	0.000217	0.00022	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PRKCG—hematologic cancer	0.000216	0.000219	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—JAK1—hematologic cancer	0.000216	0.000219	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—FOXO1—hematologic cancer	0.000216	0.000219	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—IL2—hematologic cancer	0.000216	0.000219	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PDGFRB—hematologic cancer	0.000215	0.000219	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—PIK3CB—hematologic cancer	0.000213	0.000217	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PDGFRA—hematologic cancer	0.000212	0.000215	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PRKCG—hematologic cancer	0.000211	0.000215	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—JAK1—hematologic cancer	0.000211	0.000215	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—HRAS—hematologic cancer	0.000207	0.00021	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CDKN1B—hematologic cancer	0.000204	0.000207	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IL2RA—hematologic cancer	0.000202	0.000205	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—AKT1—hematologic cancer	0.000201	0.000205	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—IL2—hematologic cancer	0.0002	0.000203	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CASP3—hematologic cancer	0.0002	0.000203	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TERT—hematologic cancer	0.000199	0.000203	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IL2—hematologic cancer	0.000199	0.000202	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—IL6—hematologic cancer	0.000198	0.000201	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IL2RA—hematologic cancer	0.000197	0.0002	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—IL2—hematologic cancer	0.000196	0.000199	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TERT—hematologic cancer	0.000195	0.000198	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PDGFB—hematologic cancer	0.000195	0.000198	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CCND1—hematologic cancer	0.000194	0.000197	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—JUN—hematologic cancer	0.000194	0.000197	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PDGFB—hematologic cancer	0.00019	0.000193	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TSC2—hematologic cancer	0.00019	0.000193	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CDKN1A—hematologic cancer	0.000188	0.000191	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PTEN—hematologic cancer	0.000187	0.00019	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TSC2—hematologic cancer	0.000186	0.000189	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MAPK8—hematologic cancer	0.000183	0.000186	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—FGFR3—hematologic cancer	0.000183	0.000186	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—AKT1—hematologic cancer	0.000183	0.000186	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MAPK14—hematologic cancer	0.000181	0.000184	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—FGFR3—hematologic cancer	0.000179	0.000182	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—EP300—hematologic cancer	0.000179	0.000182	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—ESR1—hematologic cancer	0.000178	0.000181	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MAPK14—hematologic cancer	0.000177	0.00018	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—FN1—hematologic cancer	0.000176	0.000178	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—ESR1—hematologic cancer	0.000174	0.000177	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—SRC—hematologic cancer	0.000174	0.000177	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NFKBIA—hematologic cancer	0.000174	0.000176	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—BAD—hematologic cancer	0.000174	0.000176	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NOTCH1—hematologic cancer	0.000172	0.000175	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—FN1—hematologic cancer	0.000172	0.000175	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—BAD—hematologic cancer	0.00017	0.000172	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NFKBIA—hematologic cancer	0.00017	0.000172	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—VEGFA—hematologic cancer	0.000169	0.000172	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CD80—hematologic cancer	0.000168	0.000171	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NOTCH1—hematologic cancer	0.000168	0.000171	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PIK3CG—hematologic cancer	0.000168	0.000171	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—KIT—hematologic cancer	0.000168	0.000171	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—NRAS—hematologic cancer	0.000168	0.000171	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—STAT3—hematologic cancer	0.000168	0.00017	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—NRAS—hematologic cancer	0.000167	0.00017	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PTPN11—hematologic cancer	0.000165	0.000168	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CD80—hematologic cancer	0.000165	0.000167	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PIK3CG—hematologic cancer	0.000164	0.000167	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—KIT—hematologic cancer	0.000164	0.000167	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—NRAS—hematologic cancer	0.000164	0.000167	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PTPN11—hematologic cancer	0.000162	0.000164	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—MAPK3—hematologic cancer	0.000161	0.000163	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MAPK3—hematologic cancer	0.00016	0.000163	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CREB1—hematologic cancer	0.00016	0.000163	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—BRAF—hematologic cancer	0.000158	0.00016	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—MAPK3—hematologic cancer	0.000157	0.00016	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCL2—hematologic cancer	0.000157	0.000159	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CREB1—hematologic cancer	0.000157	0.000159	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IL6R—hematologic cancer	0.000156	0.000159	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CREBBP—hematologic cancer	0.000156	0.000158	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MYC—hematologic cancer	0.000156	0.000158	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—TGFB1—hematologic cancer	0.000155	0.000158	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—BRAF—hematologic cancer	0.000155	0.000157	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCL2—hematologic cancer	0.000153	0.000156	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IL6R—hematologic cancer	0.000153	0.000155	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CREBBP—hematologic cancer	0.000152	0.000155	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MAP2K1—hematologic cancer	0.000149	0.000151	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PIK3CD—hematologic cancer	0.000148	0.00015	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—PIK3CA—hematologic cancer	0.000146	0.000149	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MAP2K1—hematologic cancer	0.000145	0.000148	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—KRAS—hematologic cancer	0.000145	0.000147	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PIK3CD—hematologic cancer	0.000145	0.000147	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—KRAS—hematologic cancer	0.000144	0.000146	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—PIK3CA—hematologic cancer	0.000143	0.000145	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—KRAS—hematologic cancer	0.000142	0.000144	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—FGF2—hematologic cancer	0.000141	0.000144	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PIK3R1—hematologic cancer	0.00014	0.000142	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—FGF2—hematologic cancer	0.000138	0.000141	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PIK3R1—hematologic cancer	0.000136	0.000139	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—JAK2—hematologic cancer	0.000136	0.000138	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—PIK3CA—hematologic cancer	0.000133	0.000135	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—JAK2—hematologic cancer	0.000133	0.000135	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MDM2—hematologic cancer	0.000132	0.000134	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PIK3CA—hematologic cancer	0.000132	0.000134	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—PIK3CA—hematologic cancer	0.00013	0.000132	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MDM2—hematologic cancer	0.000129	0.000132	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MTOR—hematologic cancer	0.000129	0.000131	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PIK3CB—hematologic cancer	0.000129	0.000131	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—TP53—hematologic cancer	0.000128	0.00013	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MTOR—hematologic cancer	0.000126	0.000128	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PIK3CB—hematologic cancer	0.000126	0.000128	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—HRAS—hematologic cancer	0.000123	0.000125	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HRAS—hematologic cancer	0.000122	0.000124	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CDKN1B—hematologic cancer	0.000121	0.000123	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—HRAS—hematologic cancer	0.00012	0.000122	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—AKT1—hematologic cancer	0.00012	0.000121	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CASP3—hematologic cancer	0.000118	0.00012	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IL2—hematologic cancer	0.000118	0.00012	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CDKN1B—hematologic cancer	0.000118	0.00012	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—IL6—hematologic cancer	0.000118	0.00012	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IL6—hematologic cancer	0.000117	0.000119	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—AKT1—hematologic cancer	0.000117	0.000119	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CASP3—hematologic cancer	0.000116	0.000118	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IL2—hematologic cancer	0.000116	0.000118	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCND1—hematologic cancer	0.000115	0.000117	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—IL6—hematologic cancer	0.000115	0.000117	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—JUN—hematologic cancer	0.000115	0.000117	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCND1—hematologic cancer	0.000113	0.000115	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—JUN—hematologic cancer	0.000113	0.000114	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CDKN1A—hematologic cancer	0.000112	0.000113	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PTEN—hematologic cancer	0.000111	0.000113	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CDKN1A—hematologic cancer	0.000109	0.000111	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MAPK8—hematologic cancer	0.000109	0.000111	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PTEN—hematologic cancer	0.000109	0.000111	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—AKT1—hematologic cancer	0.000109	0.00011	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—AKT1—hematologic cancer	0.000108	0.00011	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MAPK8—hematologic cancer	0.000106	0.000108	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—AKT1—hematologic cancer	0.000106	0.000108	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—EP300—hematologic cancer	0.000106	0.000108	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—EP300—hematologic cancer	0.000104	0.000105	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—SRC—hematologic cancer	0.000103	0.000105	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—SRC—hematologic cancer	0.000101	0.000103	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—VEGFA—hematologic cancer	0.000101	0.000102	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—STAT3—hematologic cancer	9.95e-05	0.000101	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NRAS—hematologic cancer	9.93e-05	0.000101	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—VEGFA—hematologic cancer	9.83e-05	9.99e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—STAT3—hematologic cancer	9.74e-05	9.89e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NRAS—hematologic cancer	9.71e-05	9.87e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MAPK3—hematologic cancer	9.51e-05	9.66e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MAPK3—hematologic cancer	9.3e-05	9.45e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MYC—hematologic cancer	9.25e-05	9.39e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TGFB1—hematologic cancer	9.23e-05	9.37e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MYC—hematologic cancer	9.05e-05	9.19e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TGFB1—hematologic cancer	9.02e-05	9.17e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—KRAS—hematologic cancer	8.55e-05	8.68e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—KRAS—hematologic cancer	8.36e-05	8.49e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PIK3CA—hematologic cancer	7.85e-05	7.97e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PIK3CA—hematologic cancer	7.68e-05	7.8e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TP53—hematologic cancer	7.6e-05	7.71e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TP53—hematologic cancer	7.43e-05	7.55e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HRAS—hematologic cancer	7.26e-05	7.38e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HRAS—hematologic cancer	7.11e-05	7.22e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IL6—hematologic cancer	6.95e-05	7.06e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IL6—hematologic cancer	6.8e-05	6.91e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—AKT1—hematologic cancer	6.41e-05	6.51e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—AKT1—hematologic cancer	6.27e-05	6.37e-05	CbGpPWpGaD
